Susan O’Brien

2.2k citations

56 papers · 1.3k indexed · h-index 21

Co-authors: Hagop M. Kantarjian Farhad Ravandi Jörge E. Cortes Michael J. Keating Elihu H. Estey Francis J. Giles Emil J. Freireich Catherine Donaldson
Topics: Chronic Lymphocytic Leukemia Research (35 papers)Acute Lymphoblastic Leukemia research (16 papers)Chronic Myeloid Leukemia Treatments (14 papers)
Cited by: Hematology Genetics Pathology and Forensic Medicine
Journals: Journal of Biological Chemistry Journal of Clinical Oncology Blood
Partner nations: United States Finland Japan

In The Last Decade

Susan O’Brien

54 papers receiving 1.3k citations

Peers

Countries citing papers authored by Susan O’Brien

Since Specialization

Citations

This map shows the geographic impact of Susan O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan O’Brien more than expected).

Fields of papers citing papers by Susan O’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan O’Brien. The network helps show where Susan O’Brien may publish in the future.

Co-authorship network of co-authors of Susan O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Susan O’Brien. A scholar is included among the top collaborators of Susan O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan O’Brien. Susan O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens 2015 ·Clinical Cancer Research ·(unknown),Diana E. Jaalouk,Carlos E. Bueso‐Ramos,Laura Bover,Yan Sun,Akihiko Kuniyasu,Wouter H. P. Driessen,Marina Cardó‐Vila,Cecilia Rietz,Amado J. Zurita,Susan O’Brien,Hagop M. Kantarjian,Jörge E. Cortes,George A. Călin,Erkki Koivunen,Wadih Arap,Renata Pasqualini	11
2	Novel Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia – A Focus on Emerging Monoclonal Antibodies 2013 ·Current Hematologic Malignancy Reports ·Naval Daver,Susan O’Brien	17
3	Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemia 2013 ·Leukemia & lymphoma ·Paolo Strati,Alessandra Ferrajoli,Susan Lerner,Susan O’Brien,William G. Wierda,Michael J. Keating,Stefan Faderl	8
4	Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia 2012 ·Clinical Lymphoma Myeloma & Leukemia ·Elias Jabbour,Guillermo Garcia‐Manero,Jörge E. Cortes,Farhad Ravandi,William Plunkett,Varsha Gandhi,Stefan Faderl,Susan O’Brien,Gautam Borthakur,Tapan M. Kadia,Jan A. Burger,Marina Konopleva,Mark Brandt,Xuelin Huang,Hagop M. Kantarjian	27
5	Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy 2012 ·Haematologica ·(unknown),Hagop Kantarjian,J. Shan,(unknown),Alfonso Quintás‐Cardama,Srđan Verstovšek,(unknown),William G. Wierda,Susan O’Brien,Jörge E. Cortes	63
6	Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia 2010 ·Clinical Lymphoma Myeloma & Leukemia ·Susan O’Brien,Anders Österborg	19
7	Targeting neuropilin-1 in human leukemia and lymphoma 2010 ·Blood ·(unknown),Diana E. Jaalouk,Carlos E. Bueso‐Ramos,Amado J. Zurita,Akihiko Kuniyasu,Bedrich L. Eckhardt,Frank C. Marini,Benjamin Lichtiger,Susan O’Brien,Hagop M. Kantarjian,Jörge E. Cortes,Erkki Koivunen,Wadih Arap,Renata Pasqualini	86
8	Plasma levels of JAK2 mRNA in patients with chronic myeloproliferative diseases with and without V617F mutation: implications for prognosis and disease biology 2009 ·International Journal of Laboratory Hematology ·(unknown),Hagop M. Kantarjian,(unknown),(unknown),(unknown),Srđan Verstovšek,Susan O’Brien,Francis J. Giles,Maher Albitar	3
9	Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia 2008 ·Leukemia Research ·Chen-Hsiung Yeh,(unknown),Zhong Zhang,Jörge E. Cortes,Susan O’Brien,Francis J. Giles,Alison L. Hannah,Zeev Estrov,Michael J. Keating,Hagop M. Kantarjian,Maher Albitar	23
10	Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells 2008 ·Journal of Biological Chemistry ·(unknown),Shunsuke Takahashi,(unknown),(unknown),Diana E. Jaalouk,Susan O’Brien,Erkki Koivunen,Wadih Arap,Renata Pasqualini,Hitoshi Nakayama,Akihiko Kuniyasu	45
11	New approaches to the management of Philadelphia chromosome-positive acute lymphocytic leukemia 2007 ·Current Hematologic Malignancy Reports ·Deborah A. Thomas,Susan O’Brien,Jörge E. Cortes,Hagop M. Kantarjian	1
12	Immune defects in patients with chronic lymphocytic leukemia 2005 ·Cancer Immunology Immunotherapy ·Farhad Ravandi,Susan O’Brien	101
13	A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor GX15-070 Administered Intravenously (IV) Every 3 Weeks to Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL). 2005 ·Blood ·Susan O’Brien,Thomas J. Kipps,Stefan Faderl,Michael Crump,Michael J. Keating,(unknown),(unknown),(unknown),(unknown),Jean Viallet,Bruce D. Cheson	17
14	Prediction of Prognosis Following Fludarabine Used as Secondary Therapy for Chronic Lymphocytic Leukemia 2000 ·Leukemia & lymphoma ·Michael J. Keating,Terry L. Smith,Susan Lerner,Susan O’Brien,L. E. Robertson,Hagop M. Kantarjian,Emil J. Freireich	29
15	Pilot Study of Rituximab in Refractory or Relapsed Hairy Cell Leukemia 2000 ·Susan O’Brien	11
16	Phase I study of liposomal daunorubicin in patients with acute leukemia 1999 ·Investigational New Drugs ·Jörge E. Cortes,Susan O’Brien,Elihu H. Estey,Francis J. Giles,Michael J. Keating,Hagop M. Kantarjian	45
17	A Phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia 1999 ·Cancer ·Charles Koller,H. Kantarjian,E. Feldman,Susan O’Brien,Mary Beth Rios,Elihu H. Estey,Michael J. Keating	9
18	Molecular Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia 1999 ·Blood ·Elihu H. Estey,Francis J. Giles,Hagop M. Kantarjian,Susan O’Brien,Jörge E. Cortes,Emil J. Freireich,Gabriel Lopez‐Berestein,Michael J. Keating	85
19	Sequential Homoharringtonine and Interferon- in the Treatment of Early Chronic Phase Chronic Myelogenous Leukemia 1999 ·Blood ·Susan O’Brien,Hagop M. Kantarjian,Charles Koller,Eric J. Feldman,Miloslav Beran,Michael Andreeff,Sergio Giralt,Bruce D. Cheson,Michael J. Keating,Emil J. Freireich,Mary Beth Rios,Moshe Talpaz	79
20	Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia 1990 ·Cancer ·(unknown),(unknown),Michael J. Keating,Elihu H. Estey,Susan O’Brien,Jay Schachner,K. B. McCredie,Emil J. Freireich	38

About Susan O’Brien

Susan O’Brien is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (35 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Myeloid Leukemia Treatments (14 papers). The work is most often cited by research in Hematology (587 citations), Genetics (533 citations) and Pathology and Forensic Medicine (231 citations). Susan O’Brien has collaborated with scholars based in United States, Finland and Japan. Frequent co-authors include Hagop M. Kantarjian, Farhad Ravandi, Jörge E. Cortes, Michael J. Keating, Elihu H. Estey, Francis J. Giles, Emil J. Freireich, Catherine Donaldson, Leila Diamond and Yoshinobu Shimizu. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact